Cargando…

Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine

A novel approach involving the preparation of mannose-bearing chitosan microspheres with entrapping complexes of HBV DNA and PEI was developed to improve the delivery of DNA into antigen-presenting cells (APCs) after intramuscular (i.m.) injection. Compared with the traditional chitosan microspheres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xianfeng, Liu, Bin, Yu, Xianghui, Zha, Xiao, Zhang, Xizhen, Chen, Yu, Wang, Xueyun, Jin, Yinghua, Wu, Yongge, Chen, Yue, Shan, Yaming, Chen, Yan, Liu, Junqiu, Kong, Wei, Shen, Jiacong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126484/
https://www.ncbi.nlm.nih.gov/pubmed/17630014
http://dx.doi.org/10.1016/j.jconrel.2007.05.018
_version_ 1783516156381888512
author Zhou, Xianfeng
Liu, Bin
Yu, Xianghui
Zha, Xiao
Zhang, Xizhen
Chen, Yu
Wang, Xueyun
Jin, Yinghua
Wu, Yongge
Chen, Yue
Shan, Yaming
Chen, Yan
Liu, Junqiu
Kong, Wei
Shen, Jiacong
author_facet Zhou, Xianfeng
Liu, Bin
Yu, Xianghui
Zha, Xiao
Zhang, Xizhen
Chen, Yu
Wang, Xueyun
Jin, Yinghua
Wu, Yongge
Chen, Yue
Shan, Yaming
Chen, Yan
Liu, Junqiu
Kong, Wei
Shen, Jiacong
author_sort Zhou, Xianfeng
collection PubMed
description A novel approach involving the preparation of mannose-bearing chitosan microspheres with entrapping complexes of HBV DNA and PEI was developed to improve the delivery of DNA into antigen-presenting cells (APCs) after intramuscular (i.m.) injection. Compared with the traditional chitosan microspheres, the microspheres could quickly release intact and penetrative PEI/DNA complexes. What's more, chitosan was modified with mannose to target the primary APCs such as dendritic cells (DCs) owing to the high density of mannose receptors expressing on the surface of immature DCs. After i.m. immunization, the microspheres induced significantly enhanced serum antibody and cytotoxic T lymphocyte (CTL) responses in comparison to naked DNA.
format Online
Article
Text
id pubmed-7126484
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71264842020-04-08 Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine Zhou, Xianfeng Liu, Bin Yu, Xianghui Zha, Xiao Zhang, Xizhen Chen, Yu Wang, Xueyun Jin, Yinghua Wu, Yongge Chen, Yue Shan, Yaming Chen, Yan Liu, Junqiu Kong, Wei Shen, Jiacong J Control Release Article A novel approach involving the preparation of mannose-bearing chitosan microspheres with entrapping complexes of HBV DNA and PEI was developed to improve the delivery of DNA into antigen-presenting cells (APCs) after intramuscular (i.m.) injection. Compared with the traditional chitosan microspheres, the microspheres could quickly release intact and penetrative PEI/DNA complexes. What's more, chitosan was modified with mannose to target the primary APCs such as dendritic cells (DCs) owing to the high density of mannose receptors expressing on the surface of immature DCs. After i.m. immunization, the microspheres induced significantly enhanced serum antibody and cytotoxic T lymphocyte (CTL) responses in comparison to naked DNA. Elsevier B.V. 2007-08-28 2007-05-25 /pmc/articles/PMC7126484/ /pubmed/17630014 http://dx.doi.org/10.1016/j.jconrel.2007.05.018 Text en Copyright © 2007 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhou, Xianfeng
Liu, Bin
Yu, Xianghui
Zha, Xiao
Zhang, Xizhen
Chen, Yu
Wang, Xueyun
Jin, Yinghua
Wu, Yongge
Chen, Yue
Shan, Yaming
Chen, Yan
Liu, Junqiu
Kong, Wei
Shen, Jiacong
Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
title Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
title_full Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
title_fullStr Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
title_full_unstemmed Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
title_short Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
title_sort controlled release of pei/dna complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to hbv dna vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126484/
https://www.ncbi.nlm.nih.gov/pubmed/17630014
http://dx.doi.org/10.1016/j.jconrel.2007.05.018
work_keys_str_mv AT zhouxianfeng controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT liubin controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT yuxianghui controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT zhaxiao controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT zhangxizhen controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT chenyu controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT wangxueyun controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT jinyinghua controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT wuyongge controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT chenyue controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT shanyaming controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT chenyan controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT liujunqiu controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT kongwei controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine
AT shenjiacong controlledreleaseofpeidnacomplexesfrommannosebearingchitosanmicrospheresasapotentdeliverysystemtoenhanceimmuneresponsetohbvdnavaccine